GarySGilkesonMD

Rheumatology • Charleston, SC

Lupus & Related

Professor, Medicine, Medical University of South Carolina College of Medicine

Join to view full profile

Dr. Gilkeson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gilkeson's full profile

Already have an account?

Office
171 Ashley Ave
Charleston, SC 29425
Phone+1 843-792-1414

Fax+1 843-876-5131

Summary

Dr. Gary Gilkeson is a rheumatologist in Charleston, SC and is affiliated with multiple hospitals in the area, including MUSC Health of Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 38 years. He specializes in lupus & related and is experienced in lupus nephritis and retroperitoneal fibrosis.

Education & Training

Duke University HospitalFellowship, Rheumatology, 1986 - 1989
University of North Carolina HospitalsResidency, Internal Medicine, 1979 - 1982
University of Texas Southwestern Medical SchoolClass of 1979

Certifications & Licensure

SC State Medical License 1996 - 2025
NC State Medical License 1979 - 2002
TX State Medical License 1979 - 1988
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Master of the American College of Rheumatology American College of Rheumatology, 2018
Distinguished University Professor MUSC, 2018

Clinical Trials

Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) Start of enrollment: 2018 Oct 26
Recruiting
Phase 2

Publications & Presentations

PubMed

136 citations
Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients
Ryan Webb, Jennifer A. Kelly, Emily C. Somers, Travis K. Hughes, Kenneth M. Kaufman
Annals of the Rheumatic Diseases. 2011-01-01
39 citations
Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: a possible gene-environment interaction for autoim...
Patricia A. Fraser, Wei-Zi Ding, Mehrdad Mohseni, Edward L. Treadwell, Mary Anne Dooley
The Journal of Rheumatology. 2003-02-01
46 citations
Evidence for gene–gene epistatic interactions among susceptibility loci for systemic lupus erythematosus
Travis K. Hughes, Adam Adler, Jennifer A. Kelly, Kenneth M. Kaufman, Adrienne H. Williams
Arthritis and Rheumatism. 2012-02-01

Journal Articles

Genetic Fine Mapping of Systemic Lupus Erythematosus MHC Associations in Europeans and African Americans
Gary Gilkeson, Judith A James, Jane E Salmon, Diane L Kamen, Rosalind Ramsey-Goldman, John B Harley, Robert P Kimberly, Joseph McCune, Human Molecular Genetics

Authored Content

I Saw More Posters at This Year’s ACR Meeting Than Ever BeforeNovember 2020

Press Mentions

Emory Team Awarded $3 Million to Investigate Lupus in African AmericansSeptember 21st, 2021
2020 National VA Research Week: `Empowering Veterans Through Research’May 12th, 2020
Improving Care and Educational Outreach for Lupus PatientsSeptember 17th, 2019
Join now to see all

Grant Support

Role Of Estrogen Receptors In Lupus-Modulators Of The Inflammatory ResponseVeterans Affairs2011–2012
Role Of Reactive Intermediates In Lupus NephritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2011
Training Grant In Inflammatory And Fibrosing DiseasesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2011
Systemic Lupus Erythematosus Database ProjectNational Center For Research Resources2007–2008
Genetic &Environmental Influences On The Development &Progression Of Lupus...National Institute Of Arthritis And Musculoskeletal And Skin Diseases2007
Nitric Oxide In Systemic Lupus ErythematosusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2007
Role Of PPAR Gamma In Lupus NephritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2005
Intravenous Cyclophosphamide Vs. Mycophenolate Mofetil Induction TherapyNational Center For Research Resources2004
Role Of Complement Factor B In The Pathogenesis Of SLENational Institute Of Allergy And Infectious Diseases2000–2004
Trial Of LJP 394 In Systemic Lupus ErythematosusNational Center For Research Resources2000–2002
Effect Of DMP 777upon Joint Manifestations In SLENational Center For Research Resources2000–2002
LJP 394 VS Placebo In Treatment Of SLENational Center For Research Resources1998–2002
Nitric Oxide And Systemic Lupus ErythematosusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2001
Phase 111 Trial Of LJP 394 In Patients With SLENational Center For Research Resources2000
Phase 11 Trial Of LJP 394 In Patients With SLENational Center For Research Resources2000
Renal Inflammation &FunctionNational Center For Research Resources1999–2000
Systemic Lupus ErythematosusNational Center For Research Resources1999
Syst Lupus (SLE)National Center For Research Resources1999
SLE Renal DiseaseNational Center For Research Resources1999
Joint Manifestations In SLENational Center For Research Resources1999
Molecular Genetics Of Induced Antidna ProductionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996
Immunopathogenesis Of Induced Antidna ResponsesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994
Immunopathogenesis Of Induced Anti-Dna ResponsesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1990–1993